EGFR and cancer: Indeed a modest activation of the EGFR signaling pathway has been demonstrated also in EGFR-WT NSCLC, promoting cancer cells proliferation, motility and invasiveness, stimulating tumor angiogenesis and inhibiting apoptosis processes [32, 34].